| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout
|
Marotto, Daniela
|
|
2018
|
5 |
1 |
p. 303-310
|
artikel
|
| 2 |
A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose in Iron-Deficient Patients with Fibromyalgia
|
Boomershine, Chad S.
|
|
2017
|
5 |
1 |
p. 271-281
|
artikel
|
| 3 |
A Case Report of Chikungunya Fever, Rheumatoid Arthritis, and Felty’s Syndrome
|
Amaral, José Kennedy
|
|
2018
|
5 |
1 |
p. 293-301
|
artikel
|
| 4 |
A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States
|
Spivey, Christina A.
|
|
2017
|
5 |
1 |
p. 255-270
|
artikel
|
| 5 |
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases
|
Rubbert-Roth, Andrea
|
|
2018
|
5 |
1 |
p. 21-42
|
artikel
|
| 6 |
Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis
|
Wells, Alvin F.
|
|
2018
|
5 |
1 |
p. 43-55
|
artikel
|
| 7 |
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
|
Borse, Rebekah H.
|
|
2018
|
5 |
1 |
p. 57-73
|
artikel
|
| 8 |
Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data
|
Guelfucci, Florent
|
|
2018
|
5 |
1 |
p. 171-183
|
artikel
|
| 9 |
Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States
|
Kong, Amanda M.
|
|
2018
|
5 |
1 |
p. 159-170
|
artikel
|
| 10 |
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis
|
Fleischmann, Roy
|
|
2018
|
5 |
1 |
p. 203-214
|
artikel
|
| 11 |
Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study
|
Larmore, Cynthia J.
|
|
2018
|
5 |
1 |
p. 215-229
|
artikel
|
| 12 |
Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study
|
Bessette, Louis
|
|
2018
|
5 |
1 |
p. 75-85
|
artikel
|
| 13 |
Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice
|
Perez Ruiz, Fernando
|
|
2017
|
5 |
1 |
p. 243-253
|
artikel
|
| 14 |
Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives
|
Heath-Watson, Shelly
|
|
2018
|
5 |
1 |
p. 1-4
|
artikel
|
| 15 |
Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis
|
Bassiouni, Hassan
|
|
2018
|
5 |
1 |
p. 149-158
|
artikel
|
| 16 |
Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach
|
O’Shea, Finbar
|
|
2018
|
5 |
1 |
p. 87-98
|
artikel
|
| 17 |
Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients
|
Okazaki, Masateru
|
|
2018
|
5 |
1 |
p. 185-201
|
artikel
|
| 18 |
Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases
|
Bodis, Gergely
|
|
2018
|
5 |
1 |
p. 5-20
|
artikel
|
| 19 |
Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan
|
Okazaki, Masateru
|
|
2018
|
5 |
1 |
p. 135-148
|
artikel
|
| 20 |
Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
|
Nash, Peter
|
|
2018
|
5 |
1 |
p. 99-122
|
artikel
|
| 21 |
Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial
|
Kaeley, Gurjit S.
|
|
2018
|
5 |
1 |
p. 123-134
|
artikel
|
| 22 |
Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis
|
Kivitz, Alan
|
|
2017
|
5 |
1 |
p. 231-242
|
artikel
|
| 23 |
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
|
Cohen, Stanley
|
|
2018
|
5 |
1 |
p. 283-291
|
artikel
|
Tijdschrift beschrijving